Systemic inflammation factors as survival prognosis markers in ovarian neoplasm and the relationship with cancer-associated inflammatory mediators-a review.

Dinca AL, Diaconu A, Birla RD, Coculescu BI, Dinca VG, Manole G, Marica C, Tudorache IS, Panaitescu E, Constantinoiu SM, Coculescu EC

Open source

DOI
10.1177/03946320231178769
Published
2023 Jan-Dec
Container
International journal of immunopathology and pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/03946320231178769,
  title = {Systemic inflammation factors as survival prognosis markers in ovarian neoplasm and the relationship with cancer-associated inflammatory mediators-a review.},
  author = {Dinca AL and Diaconu A and Birla RD and Coculescu BI and Dinca VG and Manole G and Marica C and Tudorache IS and Panaitescu E and Constantinoiu SM and Coculescu EC},
  year = {2023},
  journal = {International journal of immunopathology and pharmacology},
  doi = {10.1177/03946320231178769},
  url = {https://doi.org/10.1177/03946320231178769}
}

RIS

TY  - JOUR
TI  - Systemic inflammation factors as survival prognosis markers in ovarian neoplasm and the relationship with cancer-associated inflammatory mediators-a review.
AU  - Dinca AL
AU  - Diaconu A
AU  - Birla RD
AU  - Coculescu BI
AU  - Dinca VG
AU  - Manole G
AU  - Marica C
AU  - Tudorache IS
AU  - Panaitescu E
AU  - Constantinoiu SM
AU  - Coculescu EC
PY  - 2023
JO  - International journal of immunopathology and pharmacology
DO  - 10.1177/03946320231178769
UR  - https://doi.org/10.1177/03946320231178769
ER  - 

APA

AL, D., A, D., RD, B., BI, C., VG, D., G, M., C, M., IS, T., E, P., SM, C., & EC, C. (2023). Systemic inflammation factors as survival prognosis markers in ovarian neoplasm and the relationship with cancer-associated inflammatory mediators-a review.. International journal of immunopathology and pharmacology. https://doi.org/10.1177/03946320231178769

Source records